Inverse agonist activity of agouti and agouti-related protein

被引:73
作者
Chai, BX
Neubig, RR
Millhauser, GL
Thompson, DA
Jackson, PJ
Barsh, GS
Dickinson, CJ
Li, JY
Lai, YM
Gantz, I
机构
[1] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ctr Med, Dept Pediat, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Ctr Med, Dept Pharmacol & Internal Med, Ann Arbor, MI 48109 USA
[4] Univ Calif Santa Cruz, Dept Chem, Santa Cruz, CA 95064 USA
[5] Univ Calif Santa Cruz, Dept Biochem, Santa Cruz, CA 95064 USA
[6] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
[7] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA
[8] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA
关键词
melanocortin; obesity; hypothalamus; pigmentation; JKC-363; JKC-366;
D O I
10.1016/S0196-9781(03)00104-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Agouti and agouti-related protein (AgRP) are endogenous antagonists of the melanocortin receptors (MCxR). Previous data showed that recombinant full-length agouti and a synthetic fragment of AgRP, AgRP (83-132), are inverse agonists at the MC1R and MC4R, respectively. This study demonstrates the smaller analogs AgRP (87-120) and ASIP [90-132 (L89Y)], and short peptides Yc[CRFFNAFC]Y and Qc[CRFFRSAC]S are also MC4R inverse agonists. Furthermore, the relative affinity of the series of MC4R ligands for displacement of radiolabeled antagonist I-125-AgRP (86-132) versus radiolabeled agonist I-125-NDP-MSH did not correlate with ligand efficacy, which is more consistent with an induced-fit model than a simple two-state model of MC4R activation. These data shed new light on the determinants and mechanism of inverse agonism at the MC4R. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:603 / 609
页数:7
相关论文
共 29 条
  • [21] Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3
    Reizes, O
    Lincecum, J
    Wang, ZH
    Goldberger, O
    Huang, L
    Kaksonen, M
    Ahima, R
    Hinkes, MT
    Barsh, GS
    Rauvala, H
    Bernfield, M
    [J]. CELL, 2001, 106 (01) : 105 - 116
  • [22] Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014:: comparison with SHU9119
    Schiöth, HB
    Muceniece, R
    Mutulis, F
    Bouifrouri, AA
    Mutule, I
    Wikberg, JES
    [J]. NEUROPEPTIDES, 1999, 33 (03) : 191 - 196
  • [23] Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice
    Shutter, JR
    Graham, M
    Kinsey, AC
    Scully, S
    Luthy, R
    Stark, KL
    [J]. GENES & DEVELOPMENT, 1997, 11 (05) : 593 - 602
  • [24] Interactions of alpha-melanotropin and agouti on B16 melanoma cells: Evidence for inverse agonism of agouti
    Siegrist, W
    Drozdz, R
    Cotti, R
    Willard, DH
    Wilkison, WO
    Eberle, AN
    [J]. JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 1997, 17 (1-3): : 75 - 98
  • [25] Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors
    Tota, MR
    Smith, TS
    Mao, C
    MacNeil, T
    Mosley, RT
    Van der Ploeg, LHT
    Fong, TM
    [J]. BIOCHEMISTRY, 1999, 38 (03) : 897 - 904
  • [26] WOUTER AJ, 2001, MOL ENDOCRINOL, V15, P164
  • [27] Effects of recombinant agouti-signaling protein on melanocortin action
    Yang, YK
    Ollmann, MM
    Wilson, BD
    Dickinson, C
    Yamada, T
    Barsh, GS
    Gantz, I
    [J]. MOLECULAR ENDOCRINOLOGY, 1997, 11 (03) : 274 - 280
  • [28] Functional properties of an agouti signaling protein variant and characteristics of its cognate radioligand
    Yang, YK
    Dickinson, C
    Lai, YM
    Li, JY
    Gantz, I
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2001, 281 (06) : R1877 - R1886
  • [29] Characterization of Agouti-related protein binding to melanocortin receptors
    Yang, YK
    Thompson, DA
    Dickinson, CJ
    Wilken, J
    Barsh, GS
    Kent, SBH
    Gantz, I
    [J]. MOLECULAR ENDOCRINOLOGY, 1999, 13 (01) : 148 - 155